Enhanced photo(geno)toxicity of demethylated chlorpromazine metabolites

Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Palumbo F
- Limones-Herrero D
- Jiménez MC
- Miranda MA
Grupos
Abstract
Chlorpromazine (CPZ) is an anti-psychotic drug widely used to treat disorders such as schizophrenia or manic depression. Unfortunately, CPZ exhibits undesirable side effects such as phototoxic and photoallergic reactions in humans. In general, the influence of drug metabolism on this type of reactions has not been previously considered in photosafety testing. Thus, the present work aims to investigate the possible photo(geno)toxic potential drug metabolites, using CPZ as an established reference compound. In this case, the metabolites selected for the study are demethylchlorpromazine (DMCPZ), didemethylchlorpromazine (DDMCPZ) and chlorpromazine sulfoxide (CPZSO). The demethylated CPZ metabolites DMCPZ and DDMCPZ maintain identical chromophore to the parent drug. In this work, it has been found that the nature of the aminoalkyl side chain modulates the hydro-phobicity and the photochemical properties (for instance, the excited state lifetimes), but it does not change the photoreactivity pattern, which is characterized by reductive photodehalogenation, triggered by homolytic carbon-chlorine bond cleavage with formation of highly reactive aryl radical intermediates. Accordingly, these metabolites are phototoxic to cells, as revealed by the 3T3 NRU assay; their photo-irritation factors are even higher than that of CPZ. The same trend is observed in photogenotoxicity studies, both with isolated and with cellular DNA, where DMCPZ and DDMCPZ are more active than CPZ itself. In summary, side-chain demethylation CPZ, as a consequence of Phase I biotransformation, does not result a photodetoxification. Instead, it leads to metabolites that exhibit in an even enhanced photo(geno)toxicity. (C) 2016 Elsevier Inc. All rights reserved.
Datos de la publicación
- ISSN/ISSNe:
- 0041-008X, 1096-0333
- Tipo:
- Article
- Páginas:
- 131-137
- PubMed:
- 27984131
- Factor de Impacto:
- 1,496 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
Toxicology and applied pharmacology ACADEMIC PRESS INC ELSEVIER SCIENCE
Citas Recibidas en Web of Science: 14
Documentos
- No hay documentos
Filiaciones
Keywords
- Comet assay; Excited states; Laser flash photolysis; Metabolites; Photosensitized DNA damage; Phototoxicity
Proyectos y Estudios Clínicos
RED DE SALUD MATERNO-INFANTIL Y DEL DESARROLLO
RD08/0072/0022 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2008
INMADUREZ HEPATICA Y VARIABILIDAD DE LA RESPUESTA AL IBUPROFENO EN EL DUCTUS ARTERIOSO PERSISTENTE (DAP) DEL PREMATURO. ESTUDIO DE LA ACTIVIDAD CYP-450 EN PREMATUROS.
Investigador Principal: MÁXIMO VENTO TORRES
AP-203/10 . 2010
PROTECCION FRENTE AL ESTRES OXIDATIVO DE LOS PREMATUROS ALIMENTADOS CON LECHE MATERNA DONADA PROCESADA EN EL BANCO DE LECHE DEL HOSPITAL LA FE
Investigador Principal: MARÍA JOSÉ GORMAZ MORENO
GE-006/10 . 2010
ALTERACIONES METABONOMICAS EN EL PREMATURO EXTREMO DEPENDIENTES DE LA CARGA DE OXIGENO RECIBIDA EN LA REANIMACION POSTNATAL: UN ESTUDIO PROSPECTIVO ALEATORIZADO.
Investigador Principal: MÁXIMO VENTO TORRES
PI11/00313 . INSTITUTO DE SALUD CARLOS III . 2012
DEVELOPMENT OF A MECHANISTICALLY-BASED CELL ASSAY FOR ANTICIPATING THE PHOTOGENOTOXIC POTENTIAL OF BIOACTIVE CHEMICALS AND THEIR METABOLITES
CP11/00154 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2012
MULTICENTER, RANDOMIZED, BLINDED CLINICAL STUDY COMPARING EARLY USE OF TOTAL BODY MODERATE HYPOTHERMIA PLUS TOPIRAMATE OR PLACEBO IN ASPHYXIATED NEWBORN INFANTS EVOLVING TO MODERATE-TO-SEVERE HYPOXIC ISCHEMIC ENCEPHALOPATHY
Investigador Principal: MÁXIMO VENTO TORRES
EC11-244 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2012
RED DE SALUD MATERNO INFANTIL Y DEL DESARROLLO
Investigador Principal: MÁXIMO VENTO TORRES
RD12/0026/0012 . INSTITUTO DE SALUD CARLOS III; FUNDACIÓN PARA LA INVESTIGACIÓN DEL HOSPITAL UNIVERSITARIO LA FE DE LA COMUNIDAD VALENCIANA . 2013
Cita
Palumbo F,GARCIA G,Limones D,COLOMA MD,ESCOBAR J,Jiménez MC,Miranda MA,ANDREU I. Enhanced photo(geno)toxicity of demethylated chlorpromazine metabolites. Toxicol. Appl. Pharmacol. 2016. 313. p. 131-137. IF:3,791. (1).